-Yongda has established a postgraduate workstation in Jiangsu Province, a postgraduate practice base in Jiangsu University, and a research office of catalytic engineering technology for cardiovascular and cerebrovascular pharmaceutical intermediates in Changzhou City.
2014
-In order to meet the needs of future development, Yongda merged Jiangsu Yongda Pharmaceutical Co., Ltd. and Changzhou Daou Chemical Co., Ltd. through the integration of resources, forming the current Jiangsu Yongda Pharmaceutical Co., Ltd.
2005
-Yongda has invested in the construction of Changzhou Daou Chemical Co., Ltd. in Changzhou Binjiang High-tech Development Zone, and takes the high-pressure hydrogenation facility as the characteristic project of the enterprise, and continuously optimizes the product structure around this technology, so that the enterprise can obtain considerable development.
2003
-Yongda established Jiangsu Yongda Pharmaceutical Co., Ltd. on the basis of the original, and officially entered the pharmaceutical field with the raw material "gatifloxacin", and obtained the GMP certificate of nateglinide, balofloxacin and other raw materials in the following 10 years.
1992
-Yongda's predecessor, Jiangyin Yongda Chemical Co., Ltd., was established in Huangtu Town, Jiangyin City. The representative product "monochloroacetone" laid the foundation for the development of Yongda.